There appears to be a mixture of performance for
Colgate-Palmolive Co. as reflected by several reports. The stock often
outperformed competitors on several trading days despite certain losses. Analysts' consensus points to a
'Moderate Buy' rating, with Morgan Stanley raising the price target to
$103.00. Evident in Q1 and Q4 2023 earnings are high performances expected to continue in Q1 2024. The company's intrinsic value is suggested to be potentially
38% higher than its share price. Colgate-Palmolive's debt level is considered sensible, thereby reducing investment risks. The stock experienced over
15% rise within the year and a dividend increase to
$0.50. Its steady growth is attributed to strategic efforts, strong pricing, and sales beat. Additionally, institutional owners majorly favor the company, holding
80%-83% of it. Investing five years ago would have yielded an impressive
51% gain. At present, the company is deemed a
great dividend stock where shareholders may expect bigger dividends than the previous year.
Colgate-Palmolive Company CL News Analytics from Thu, 07 Sep 2023 07:00:00 GMT to Sat, 01 Jun 2024 05:40:54 GMT -
Rating 6
- Innovation 2
- Information 8
- Rumor -3
